Observations with Bazoton in the management of prostatic hyperplasia.

Abstract

Thirty patients with prostatic hyperplasia stages I and II were administered Bazoton capsules (extract of Radix Urticae) for an average period of 3.5 months. Residual urine, mean and maximal flow were measured before and after treatment. A significant decrease in the volume of residual urine was found. Increase in mean urinary flow was also significant. Maximal urinary flow increased in 50% of the cases. A marked subjective relief was reported by the patients. Bazoton is regarded as suitable for the conservative treatment of prostatic hyperplasia stages I and II.

• Authors: I Romics
• Journal: International urology and nephrology (Int Urol Nephrol) Vol. 19 Issue 3 Pg. 293-7 ( 1987) ISSN: 0301-1623 [Print] Netherlands
• PMID: 2444548 (Publication Type: Journal Article)

Chemical References

• Plant Extracts
• Bazoton

Topics

• Humans
• Male
• Middle Aged
• Plant Extracts (therapeutic use)
• Prostatic Hyperplasia (drug therapy)